Nrf2 is overexpressed in pancreatic cancer: implications for cell proliferation and therapyAdam Lister, B. Kevin Park, Eithne Costello et al.|Molecular Cancer|2011Cited by 240
Combined p53 and MDM2 biomarker analysis shows a unique pattern of expression associated with poor prognosis in patients with renal cell carcinoma undergoing radical nephrectomyAidan P. Noon, Mark T. Boyd, Radosław Polański et al.|British Journal of Urology|2011Cited by 35